MedPath

TRIUMEQ 50 MG/600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

TRIUMEQ 50 MG/600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Commercialized
Register Number

114940001

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Oct 14, 2014

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number114940001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (3)

ABACAVIR SULFATOActive
Quantity: 702,0 mg
Name: ABACAVIR SULFATO
DOLUTEGRAVIR SODIOActive
Quantity: 52,6 mg
Name: DOLUTEGRAVIR SODIO
LAMIVUDINAActive
Quantity: 300 mg
Name: LAMIVUDINA

ATC CLASSIFICATION (3)

J05A
J05AR
J05AR13

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.